Cargando…

Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study

OBJECTIVES: Rheumatic and musculoskeletal diseases (RMDs) require a tailored follow-up that can be enhanced by the implementation of innovative tools. The Digireuma study aimed to test the feasibility of a hybrid follow-up utilizing an electronic patient reported outcomes (ePROs)-based monitoring st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benavent, D., Fernández-Luque, L., Sanz-Jardón, M., Bilionis, I., Novella-Navarro, M., Navarro-Compán, V., González-Sanz, P. L., Calvo, E., Lojo, L., Balsa, A., Plasencia-Rodríguez, Ch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518964/ https://www.ncbi.nlm.nih.gov/pubmed/37749656 http://dx.doi.org/10.1186/s41927-023-00362-7

Ejemplares similares

Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments—Results of the digireuma study
por: Benavent, Diego, et al.
Publicado: (2022)

Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization
por: Benavent, Diego, et al.
Publicado: (2021)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
por: Benavent, Diego, et al.
Publicado: (2023)

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022)

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
por: Benavent, Diego, et al.
Publicado: (2020)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
por: Bogas, Patricia, et al.
Publicado: (2021)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
por: Novella-Navarro, Marta, et al.
Publicado: (2021)

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2022)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2020)

Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1)
por: Harrison, Stephanie Rose, et al.
Publicado: (2021)

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review
por: Navarro-Compán, Victoria, et al.
Publicado: (2017)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Neurology of musculoskeletal and rheumatic disorders /
por: Nakano, Kenneth K.
Publicado: (1979)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic
por: Stradner, Martin H., et al.
Publicado: (2020)

Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
por: Benavent, Diego, et al.
Publicado: (2022)

Advancing frontiers in rheumatic and musculoskeletal imaging
por: Albano, Domenico, et al.
Publicado: (2021)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2019)

Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases
por: Palmer, J. L., et al.
Publicado: (2021)

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)

Priorities for rheumatic and musculoskeletal disease research in Ireland
por: Dorris, Emma R., et al.
Publicado: (2022)

Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
por: Nuño, Laura, et al.
Publicado: (2020)

Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
por: Novella -Navarro, Marta, et al.
Publicado: (2023)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
por: Benavent, Diego, et al.
Publicado: (2022)

Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?
por: Tornero, C., et al.
Publicado: (2020)

Key Challenges in Rheumatic and Musculoskeletal Disease Translational Research
por: Fearon, Ursula, et al.
Publicado: (2014)

Biomarkers and Nutrients in Musculoskeletal Disorders
por: Calvo-Lobo, César, et al.
Publicado: (2021)

An Artificial Intelligence–Driven Digital Health Solution to Support Clinical Management of Patients With Long COVID-19: Protocol for a Prospective Multicenter Observational Study
por: Fuster-Casanovas, Aïna, et al.
Publicado: (2022)

Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases
por: Billiet, Lieven, et al.
Publicado: (2016)

The Third Eye of the Rheumatologist: Applications of Musculoskeletal Ultrasound in Rheumatic Diseases
por: Chen, Hsin-Hua
Publicado: (2017)

Evaluation of physical performance in musculoskeletal and rheumatic diseases with jumping mechanography
por: Dionyssiotis, Yannis, et al.
Publicado: (2019)

Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
por: Talarico, Rosaria, et al.
Publicado: (2023)

Challenges of translating epidemiologic research: An application to rheumatic and musculoskeletal disorders
por: Lucas, Raquel
Publicado: (2021)

Polychromatic flow cytometry in evaluating rheumatic disease patients
por: Wei, Chungwen, et al.
Publicado: (2015)

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mdbjskt8chgj26ntios17j2ppg